SCHEMBL20049286

SCHEMBL20049286

Cc1nc2cc(Br)c(C(C)(C)C)cc2s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.55
NPC1 O15118 4/20 0.55
RAB9A P51151 4/20 0.55
HSD17B10 Q99714 2/20 0.55
ALDH1A1 P00352 2/20 0.55
TP53 P04637 1/20 0.55
MAPT P10636 1/20 0.55
PKM P14618 1/20 0.55
HPGD P15428 1/20 0.55
GAA P10253 1/20 0.52
ALOX15 P16050 1/20 0.40
ATM Q13315 1/20 0.40
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24910454 0.85 SMN1; SMN2 (0.63) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL20043214 0.83 PPOX (0.33) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL14093001 0.79 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL20048893 0.79 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL8977888 0.78 GAA (0.70) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL24910474 0.77 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL25424052 0.75 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL21604553 0.75 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL20049285 0.75 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1
SCHEMBL4384430 0.74 SMN1; SMN2 (0.85) SMN1; SMN2NPC1RAB9AHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067704-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2018-04-12 WO disclosed